Local Institution - 2122 is a clinical research site located in Aurora, Colorado, United States 80045.
Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.
Local Institution - 2122 has participated in 1 clinical trials.
Therapeutic areas: Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET Gene Mutation.
Sponsors: Turning Point Therapeutics, Inc..
Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Local Institution - 2122 has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Local Institution - 2122 has 1 clinical trials on record. Their work covers Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET Gene Mutation.
Local Institution - 2122 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.